IPR2016-00408 (Boehringer Ingelheim) (U.S. Patent No. 8,889,135)
- Petitioner: Boehringer Ingelheim Corp., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp.
- Patent: U.S. Patent No. 8,889,135
- Patent Title: Methods of Administering Anti-TNFα Antibodies
- Patent Owner: AbbVie Biotechnology Ltd.
IPR2016-00409 (Boehringer Ingelheim) (U.S. Patent No. 8,889,135)
- Petitioner: Boehringer Ingelheim Corp., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp.
- Patent: U.S. Patent No. 8,889,135
- Patent Title: Methods of Administering Anti-TNFα Antibodies
- Patent Owner: AbbVie Biotechnology Ltd.